Zinzino released its preliminary sales results for August 2026. Total group revenue grew 15% year-over-year to $28 million. Zinzino’s sales markets saw a 16% increase, reaching approximately $27.9 million, while Faun Pharma’s external sales fell from approximately $338,000 to approximately $130,000. In total, accumulated revenue for the first eight months of 2026 increased by 22%, totaling $245 million.

Zinzino announced its preliminary sales results for May 2026. Revenue during the month grew by 14% year-over-year to $33 million. The company’s accumulated revenue for January through May 2026 grew by 23% year-over-year to $163 million.

Zinzino announced its preliminary sales results for 2025. Group revenue increased 46% in the fourth quarter, reaching $113 million, and contributing to a full year 2025 revenue increase of 51%, when compared to 2024.